Reaction Details |
| Report a problem with these data |
Target | Beta-2 adrenergic receptor |
---|
Ligand | BDBM50318153 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_632379 (CHEMBL1115584) |
---|
Ki | >10000±n/a nM |
---|
Citation | Baur, F; Beattie, D; Beer, D; Bentley, D; Bradley, M; Bruce, I; Charlton, SJ; Cuenoud, B; Ernst, R; Fairhurst, RA; Faller, B; Farr, D; Keller, T; Fozard, JR; Fullerton, J; Garman, S; Hatto, J; Hayden, C; He, H; Howes, C; Janus, D; Jiang, Z; Lewis, C; Loeuillet-Ritzler, F; Moser, H; Reilly, J; Steward, A; Sykes, D; Tedaldi, L; Trifilieff, A; Tweed, M; Watson, S; Wissler, E; Wyss, D The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist. J Med Chem53:3675-84 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-2 adrenergic receptor |
---|
Name: | Beta-2 adrenergic receptor |
Synonyms: | ADRB2 | ADRB2R | ADRB2_HUMAN | B2AR | Beta-2 adrenoceptor | Beta-2 adrenoreceptor |
Type: | n/a |
Mol. Mass.: | 46461.69 |
Organism: | Homo sapiens (Human) |
Description: | P07550 |
Residue: | 413 |
Sequence: | MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAK
FERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTAS
IETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQE
AINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRF
HVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQD
NLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNT
GEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
|
|
|
BDBM50318153 |
---|
n/a |
---|
Name | BDBM50318153 |
Synonyms: | (2S,3S,4S,5R,6S)-6-(5-((R)-2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-2-oxo-1,2-dihydroquinolin-8-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid | CHEMBL1095305 |
Type | Small organic molecule |
Emp. Form. | C30H36N2O9 |
Mol. Mass. | 568.6148 |
SMILES | CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c2[nH]c(=O)ccc12 |r| |
Structure |
|